GoodCell

GoodCell (LifeVault Bio) is a biotechnology company decoding human health to extend and improve the quality of life through technology powered by science.

GoodCell helps you take control of your health through personalized biobanking of cells, DNA and blood plasma.

GoodCell was founded in 2016 by Trevor Perry, Brad Hamilton, and David Scadden. The company is headquartered in Waltham, Massachusetts.

 

GoodCell’s vision is to give every person control over their health by providing access to a science- backed, technology-forward platform that decodes the common language of his or her cells and extends the quality of life for individuals, their families and all of humankind.

 

GoodCell's platform uniquely combines personal biobanking, diagnostics and data and is designed to provide individuals and their families the ability to securely test, track and respond to health risks, while enabling the scientific community to advance diagnostics and drug development at scale to create next-generation safeguards for global health.

 

GoodCell is backed by Delta Global Investment Services, Intellectual Digital Corp. (iDC) and others. The company raised $17.9M in a new preferred equity round on Oct 26, 2020. This brings GoodCell's total funding to $23.5M to date.

 

 

  • Year founded: 2016
  • Funding Info: $23.5M over 3 Rounds (Latest Funding Type: Venture- Series Unknown)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Waltham
  • State: Massachusetts
  • Country: United States
Related businesses